Meridian Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.56M | Buy |
6,304
+75
| +1% | +$76.6K | 0.86% | 29 |
|
|
2026
Q1 | $5.73M | Sell |
6,229
-145
| -2% | -$147K | 0.76% | 34 |
|
|
2025
Q4 | $6.85M | Sell |
6,374
-74
| -1% | -$70.8K | 0.95% | 27 |
|
|
2025
Q3 | $4.92M | Buy |
6,448
+68
| +1% | +$50.6K | 0.7% | 40 |
|
|
2025
Q2 | $4.97M | Sell |
6,380
-24
| -0.4% | -$18.6K | 0.79% | 34 |
|
|
2025
Q1 | $5.29M | Sell |
6,404
-459
| -7% | -$382K | 0.9% | 33 |
|
|
2024
Q4 | $5.3M | Sell |
6,863
-29
| -0.4% | -$24K | 0.87% | 32 |
|
|
2024
Q3 | $6.11M | Sell |
6,892
-8
| -0.1% | -$7.19K | 1.02% | 24 |
|
|
2024
Q2 | $6.25M | Sell |
6,900
-213
| -3% | -$170K | 1.11% | 24 |
|
|
2024
Q1 | $5.53M | Sell |
7,113
-56
| -0.8% | -$39.9K | 1.04% | 26 |
|
|
2023
Q4 | $4.18M | Buy |
7,169
+2
| +0% | +$1.17K | 0.92% | 32 |
|
|
2023
Q3 | $3.85M | Sell |
7,167
-46
| -0.6% | -$23.7K | 0.96% | 28 |
|
|
2023
Q2 | $3.38M | Buy |
7,213
+3
| +0% | +$1.26K | 0.82% | 31 |
|
|
2023
Q1 | $2.48M | Buy |
7,210
+102
| +1% | +$34.4K | 0.62% | 44 |
|
|
2022
Q4 | $2.6M | Sell |
7,108
-107
| -1% | -$37.9K | 0.67% | 41 |
|
|
2022
Q3 | $2.33M | Buy |
7,215
+220
| +3% | +$69.7K | 0.66% | 37 |
|
|
2022
Q2 | $2.27M | Buy |
6,995
+1,615
| +30% | +$485K | 0.6% | 44 |
|
|
2022
Q1 | $1.54M | Buy |
5,380
+1,175
| +28% | +$302K | 0.36% | 63 |
|
|
2021
Q4 | $1.16M | Buy |
4,205
+2
| +0% | +$507 | 0.28% | 78 |
|
|
2021
Q3 | $971K | Sell |
4,203
-5
| -0.1% | -$1.23K | 0.27% | 80 |
|
|
2021
Q2 | $966K | Buy |
4,208
+463
| +12% | +$93K | 0.27% | 80 |
|
|
2021
Q1 | $700K | Sell |
3,745
-137
| -4% | -$26.8K | 0.23% | 84 |
|
|
2020
Q4 | $655K | Sell |
3,882
-42
| -1% | -$6.27K | 0.24% | 88 |
|
|
2020
Q3 | $581K | Buy |
3,924
+48
| +1% | +$7.43K | 0.25% | 85 |
|
|
2020
Q2 | $636K | Buy |
3,876
+918
| +31% | +$141K | 0.29% | 76 |
|
|
2020
Q1 | $410K | Buy |
2,958
+350
| +13% | +$48.1K | 0.23% | 83 |
|
|
2019
Q4 | $343K | Buy |
2,608
+400
| +18% | +$46.4K | 0.14% | 120 |
|
|
2019
Q3 | $247K | Buy |
+2,208
| New | +$246K | 0.11% | 134 |
|
|
2019
Q2 | – | Sell |
-1,746
| Closed | -$227K | – | 133 |
|
|
2019
Q1 | $227K | Buy |
1,746
+100
| +6% | +$12.2K | 0.17% | 111 |
|
|
2018
Q4 | $190K | Buy |
+1,646
| New | +$184K | 0.15% | 120 |
|
Other funds holding LLY
Meridian Wealth Advisors's LLY Position: Q2 2026 in Review
Meridian Wealth Advisors increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $76.6K and bringing the position to 6,304 shares worth $7.56M. The position accounts for 0.86% of the portfolio, ranked #29.
Meridian Wealth Advisors first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Meridian Wealth Advisors held 6,304 shares of Eli Lilly worth $7.56M as of Q2 2026.
- Meridian Wealth Advisors bought 75 Eli Lilly shares in Q2 2026, an estimated $76.6K.
- Eli Lilly made up 0.86% of Meridian Wealth Advisors's portfolio in Q2 2026, its #29 holding.
- Meridian Wealth Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Meridian Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.